BCI
KMTS

Bain Capital Investors’s Kestra Medical Technologies KMTS Stock Holding History

Bain Capital Investors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$502M Hold
25,172,338
– – 15.35% 4
2025
Q4 		$668M Sell
25,172,338
-1,846,887
-7% -$47.6M 14.44% 3
2025
Q3 		$642M Hold
27,019,225
– – 19.15% 3
2025
Q2 		$448M Hold
27,019,225
– – 14.28% 3
2025
Q1 		$673M Buy
+27,019,225
New +$621M 17.34% 4

Other funds holding KMTS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bain Capital Investors's KMTS Position: Q1 2026 in Review

Bain Capital Investors held its Kestra Medical Technologies (KMTS) position steady in Q1 2026 at 25,172,338 shares worth $502M. The position accounts for 15.35% of the portfolio, ranked #4.

Bain Capital Investors first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $673M in Q1 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Bain Capital Investors held 25,172,338 shares of Kestra Medical Technologies worth $502M as of Q1 2026.
  • Bain Capital Investors left its Kestra Medical Technologies share count unchanged in Q1 2026.
  • Kestra Medical Technologies made up 15.35% of Bain Capital Investors's portfolio in Q1 2026, its #4 holding.
  • Bain Capital Investors first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Bain Capital Investors's Kestra Medical Technologies position peaked at $673M in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Bain Capital Investors's 13F filing for Q1 2026, filed 15 May 2026.